About Molecular Staging
Molecular Staging was a Healthcare company based in New Haven (United States) founded in 1998. It provides advanced molecular diagnostics and amplification for genomics and proteomics research. It operates on a B2B and Direct Sales model. Molecular Staging has raised $49.55 million across 14 funding rounds from investors including Orbimed, Investor and OSTI.GOV. The company is recorded as dissolved. Molecular Staging offers products and services including Protein Microarrays, Whole-Genome Amplification, and Multiplexed Diagnostics. Its focus areas include Health Care, Diagnostics Tech, Genomics and Protein Detection. Its legal entity is Molecular Staging Inc. Its competitors include OriGene, Meridian Bioscience and Teknova; 1 of its 3 listed competitors has raised funding.
Company details
Molecular Staging Inc. focuses on innovative technologies for the detection and measurement of proteins and nucleic acids, addressing demands in the life science industry. It offers products like protein microarrays and whole-genome amplification to enable faster genomics and proteomics analysis. Based in San Jose, United States, the company serves researchers and healthcare markets by developing gene-based tests and immunoassays for diseases such as cancer and infectious disorders, emphasizing sensitivity and multiplexing advantages.
- Headquarters New Haven, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website molecularstaging.com
- Legal Name Molecular Staging Inc.
- Total Equity Funding$49.55M (USD)
in 14 rounds
- Latest Funding Round$640.39K (USD), Grant
Apr 2011
- InvestorsOrbimed
& 5 more
Products & Services of Molecular Staging
Molecular Staging offers a comprehensive portfolio of products and services, including Protein Microarrays, Whole-Genome Amplification, and Multiplexed Diagnostics.
High-coverage arrays for studying multiple proteins simultaneously in research.
Amplification method making DNA samples renewable for repeated testing.
Ultra-sensitive tests for early disease detection and cost reduction.
Funding Insights of Molecular Staging
Molecular Staging has successfully raised a total of $49.55M across 14 strategic funding rounds. The most recent funding activity was a Grant round of $640.39 thousand completed in April 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $49.55M
- Total Rounds 14
- Last Round Grant — $640,387
- First Round $8.25M
(Mar 1998)
- Investors Count 6
Latest 10 of 14 funding rounds of Molecular Staging with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2011 | $640,387 | Grant | – | – | |
| Jul 2004 | $640,387 | Grant | – | – | |
| Jun 2004 | $2.05M | Grant | – | – | – |
| Jun 2003 | $300,000 | Grant | – | – | – |
| Jun 2003 | $99,644 | Grant | – | – | – |
| Jun 2003 | $750,000 | Grant | – | – | – |
| Feb 2003 | $2.5M | Grant | – | – | – |
| Jul 2002 | $640,387 | Grant | – | – | |
| Jun 2002 | $100,000 | Grant | – | – | – |
| Jun 2002 | $99,995 | Grant | – | – | – |
6 investors in total: 6 institutional.
Investors in Molecular Staging
Molecular Staging has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Orbimed, Investor and OSTI.GOV.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are directed by the Wallenberg family into Nordic sectors. | 1916 | investorab.com | Stockholm, Sweden | |
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields. | 1989 | orbimed.com | New York, United States | |
| cooperhillpartners.tcc.mode | ||||
Corporate-backed venture capital firm focused on fintech, energy, and multiple sectors | investorgrowthcapital.com | New York, United States | ||
Scientific and technical information is managed and disseminated by OSTI.GOV. | osti.gov | Oak Ridge, United States | ||
| cibcwm.com |
Investor details for Molecular Staging
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Molecular Staging
3 dated milestones of Molecular Staging across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Molecular Staging is founded.
- Funding First funding round of $8.2M.
- Funding Latest funding round, Grant, of $640K.
Competitors of Molecular Staging
Molecular Staging has 3 listed competitors in our database, 1 of them funded. They include OriGene, Meridian Bioscience and Teknova.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| origene.com | 1996 | Rockville, United States | $69.55M | 141 | Proteins, antibodies, and molecular tools are manufactured for research applications. | |
| meridianbioscience.com | 1976 | Ohio, United States | Molecular diagnostic device and kits | |||
| teknova.com | 1996 | Hollister, United States | 290 | Molecular biology reagents and kits are supplied for research applications. |
Detailed competitors of Molecular Staging
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Clinical Genomics
3 companies that operate in the same segment as Molecular Staging (Clinical Genomics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | 520 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Molecular Staging
Molecular Staging was founded in 1998.
Molecular Staging is headquartered in New Haven, United States. It is registered at New Haven, Connecticut, United States.
Molecular Staging is a funded company, having raised a total of $49.55M across 14 funding rounds to date. The company's 1st funding round was a Grant of $100K, raised on Mar 1998.
Molecular Staging Inc. focuses on innovative technologies for the detection and measurement of proteins and nucleic acids, addressing demands in the life science industry. It offers products like protein microarrays and whole-genome amplification to enable faster genomics and proteomics analysis. Based in San Jose, United States, the company serves researchers and healthcare markets by developing gene-based tests and immunoassays for diseases such as cancer and infectious disorders, emphasizing sensitivity and multiplexing advantages.
Molecular Staging's top competitors include Meridian Bioscience, Teknova and OriGene.
Molecular Staging offers Protein Microarrays, Whole-Genome Amplification, and Multiplexed Diagnostics.
Molecular Staging operates through Molecular Staging Inc..